Visual And Refractive Outcomes In Patients Following Icl Implantation Over A Three Year Period

Published 2022 - 40th Congress of the ESCRS

Reference: PP27.11 | Type: Free paper | DOI: 10.82333/x5pd-4529

Authors: Alex Shortt* ¹ , Amir Hamid ² , Shafiq Rehman ² , Irene Sisó-Fuertes ² , Nabila Jones ² , Clare ODonnell ²

¹Eye Sciences,Optegra Eye Health Care,London,United Kingdom, ²Eye Sciences,Optegra Eye Health Care,Manchester,United Kingdom

Purpose

To report consecutive postoperative visual and refractive outcomes over a three year period in patients following implantable collamer lens procedures (ICLs).

Setting

Optegra Eye Hospitals, UK

Methods

A retrospective audit of visual and refractive outcomes of consecutive patients following EVO Visian ICL implantation (Staar Surgical) for the correction of high ametropia between January 2017 and October 2020 was conducted. Data audited were recorded in an electronic medical record typically at 3 months post-operatively. Procedures were excluded from the analysis if they were enhancement procedures, amblyopic cases or had been followed up for less than one week.

Results

Data from 511 eyes with mean± SD pre-op spherical equivalent (D) -6.77 ± 6.26D; range +9.25 to -17.63 D were obtained. Complications rates were low. 77 % of eyes had a SEQ within ±0.50D of predicted target. Postoperatively, 68% of myopic and 44% of hyperopic eyes achieved 20/20 or better UDVA. Binocularly 89% of myopic patients and 63% of hyperopic patients achieved 20/20 respectively.

Conclusions

Our data show that post-operative visual and refractive outcomes were favourable in terms of uncorrected distance visual acuity and refractive outcome in these highly ametropic patients. ICLs remain a safe and efficacious option for high ametropic patients seeking spectacle independence.